dalfopristin

dalfopristin

 [dal-fo´pris-tin]
a semisynthetic antibacterial effective against a variety of gram-positive organisms. It is used in conjunction with quinupristin in the treatment of serious bacteremia caused by vancomycin-resistant Enterococcus faecium and complicated skin and skin structure infections caused by Streptococcus pyogenes or methicillin-sensitive Staphylococcus aureus; administered intravenously.

dalfopristin

/dal·fo·pris·tin/ (dal-fo´pris-tin) a semisynthetic antibacterial used in conjunction with quinupristin against various gram-positive organisms, including vancomycin-resistant Enterococcus faecium.

dalfopristin

[dalfo′pristin]
a semisynthetic antibacterial effective against a variety of gram-positive organisms. It is used in conjunction with quinupristin in the treatment of serious bacteremia caused by vancomycin-resistant Enterococcus faecium and complicated skin and skin structure infections caused by Streptococcus pyogenes or methicillin-sensitive Staphylococcus aureus; it is administered intravenously.

dalfopristin

See Synercid®.
Mentioned in ?
References in periodicals archive ?
8) dalfopristin Antibiotic VSE (N = 20), n (%) Susceptible Intermediate Resistant Erythromycin 12 (60) 6 (30) 2 (10) Ampicillin 9 (45) 6 (30) 5 (25) Vancomycin 20 (100) -- -- Teicoplanin 20 (100) -- -- Tetracycline 10 (50) 2 (10) 8 (40) Doxycycline 16 (80) 1 (5) 3 (15) Ciprofloxacin 7 (35) 4 (20) 9 (45) Levofloxacin 11 (55) 2 (10) 7 (35) Nitrofurantoin 20 (100) -- -- Rifampicin 2 (10) 9 (45) 9 (45) Linezolid 20(100) -- -- Tigecyclin 20 (100) -- -- Quinupristin/ 8 (40) 5 (25) 7 (35) dalfopristin
Intestinal colonization of vancomycin-resistant enterococci isolates among patients in an Iranian hospital
Tn5406, a New Staphylococcal Transposon Conferring Resistance to Streptogramin A and Related Compounds Including Dalfopristin.
The role of mobile genetics elements in the emergence of superbugs
AMP--ampicillin, IMP--imipenem, VA--vancomycin, LZD--linezolid, QD--quinupristin/ dalfopristin, SXT--trimethoprim/sulfamethoxazole, TGC--tigecycline.
Occurrence of high-level aminoglycoside resistance (HLAR) among enterococcus species strains
For patients who have recently suffered from infection with vancomycin resistant Enterococcus (VRE) or MRSA, prophylaxis with linzolid, or quinupristin / dalfopristin can be considered.
COMPARISON BETWEEN SINGLE AND MULTIPLE DAYS TREATMENT WITH PARENTERAL CEFUROXIME IN INGUINAL HERNIA MESH REPAIR SURGERY
Treatment of hospitalized patients with complicated gram-positive skin and skin structure infections: Two randomized, multicentre studies of quinupristin/ dalfopristin versus cefazolin, oxacillin or vancomycin.
MRSA otorrhea: a case series and review of the literature
Vancomycin, linezolid, gentamicin, moxifloxacin, quinupristin/ dalfopristin, and rifampicin were 100% effective (susceptible).
Methicillin resistant staphylococcus aureus: carriage rates and characterization of students in a Texas University
Concentracion Inhibitoria Minima Cepas de SCN Quinopristin / dalfopristin ([micro]g/mL) Numero Porcentaje 0.
Caracterizacion fenotipica de cepas de Staphylococcus coagulasa negativa aisladas de una unidad de alto riesgo neonatal
The dalfopristin component interferes with early phases of bacterial protein synthesis and quinipristin interferes with the late phase of protein synthesis.
Resistant 'superbugs' create need for novel antibiotics
Treatment of methicillin - resistant Staphylococcus aureus infections with quinupristin - dalfopristin in patients intolerant of or failing prior therapy.
PREVALENCE OF MRSA IN A PERIPHERAL HOSPITAL OF LAHORE
5 mg/kg BID Vancomycin- dalfopristin resistant enterococci Linezolid 7.
Guideline for the diagnosis, prevention and treatment of paediatric ventilator-associated pneumonia

Medical browser ?
Full browser ?